logo
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience

Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience

Yahoo10-02-2025
TUSTIN, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the launch of its new corporate website. The new site, which can be visited at www.avidbio.com, combines Avid's elevated brand story and visual identity with improved functionality and navigation, all aimed at enhancing the visitor experience, particularly for current and prospective customers.
The reimagined Avid website captures the company's elevated brand through the tagline, 'Discover the Avid effect.™', helping educate visitors on the differentiation that positions the company as one of the industry's leading, most trusted biologics CDMOs. It offers a completely revamped customer experience highlighted by user-friendly navigation, improved accessibility, video interaction, and educational resources.
'As a company that places the highest priority on delivering exceptional quality service and exceeding the expectations of our customers, we felt compelled to bring that same ethos to our online presence,' said Nick Green, president and chief executive officer of Avid. 'We take great pride in unveiling our new company website as a showcase to the Avid brand, capturing the spirit of our team, our unrivaled expertise, world-class facilities, and personalized process. For those that already have a relationship with Avid, we expect the new site will align with their experience. For those just getting to know us, we hope it will serve as a trusted and valuable resource for exploration, education, and engagement.'
About Avid Bioservices, Inc.
Avid Bioservices (NASDAQ: CDMO) is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With more than 30 years of experience producing biologics, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com
CONTACT: Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) Vida Strategic Partners 415-675-7402 tbrons@vidasp.comSign in to access your portfolio
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NVIDIA Corporation (NVDA)'s CEO Has A Great Relationship With Trump, Says Jim Cramer
NVIDIA Corporation (NVDA)'s CEO Has A Great Relationship With Trump, Says Jim Cramer

Yahoo

time24 minutes ago

  • Yahoo

NVIDIA Corporation (NVDA)'s CEO Has A Great Relationship With Trump, Says Jim Cramer

We recently published . NVIDIA Corporation (NASDAQ:NVDA) is one of the stocks Jim Cramer recently discussed. After bleeding close to $600 billion in market value in January amidst the DeepSeek selloff, Wall Street's AI chip darling, NVIDIA Corporation (NASDAQ:NVDA) is once again the most valuable company in the world. The firm has benefited from growing investor bullishness about the long-term prospects of AI. NVIDIA Corporation (NASDAQ:NVDA)'s shares closed the week 1% higher after big tech's continued persistence to spend billions of dollars to buy AI chips. Cramer discussed the impact and the CEO's relationship with President Trump: 'All CapEx go up, it's all NVIDIA. . .it's really good for NVIDIA. But of course, NVIDIA, the President talking about breaking them up, we'll get to that later. It was an out of body comment. Previously, the CNBC TV host commented on NVIDIA Corporation (NASDAQ:NVDA)'s shares and parabolic moves: 'What is the solution to this? Look, in my forthcoming book, How to Make Money in Any Market, I have banished my antiparabola bias. I have a method I reveal of picking five stocks to go alongside an index fund with some money added each month. I state point blank that if you are in your 30s or older, you should own one speculative situation like an Oklo, okay, or a Joby. Just one. It could fail you after going parabolic. Moreover, if you're under 30, you can pick two speculative names out of five because you've got enough time to make back any potential losses. Photo by Javier Esteban on Unsplash Now, you may think I'm reckless for endorsing any of these even with caveats, but it's time to admit that for many years now, speculative stocks with great growth, they've worked. Oh, and let's not forget, they don't have to stay speculative. NVIDIA stock has had many parabolic moves, including the one that started in April. To keep yourself out of these runs because of a principle that stopped working ages ago, that's to be blind to change, and I don't like it. I don't want to be that way.' While we acknowledge the potential of NVDA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Alphabet Inc. (GOOGL): 'This Stock Should Be Up Much More,' Says Jim Cramer
Alphabet Inc. (GOOGL): 'This Stock Should Be Up Much More,' Says Jim Cramer

Yahoo

timean hour ago

  • Yahoo

Alphabet Inc. (GOOGL): 'This Stock Should Be Up Much More,' Says Jim Cramer

We recently published . Alphabet Inc. (NASDAQ:GOOGL) is one of the stocks Jim Cramer recently discussed. Cramer regularly discussed tech mega-cap Alphabet Inc. (NASDAQ:GOOGL) ahead of its earnings. The firm's shares have reversed course in July and are up by 1.9% year-to-date, primarily due to July's 9.9% gain. Before the report, Cramer was explicit in sharing that he regretted selling Alphabet Inc. (NASDAQ:GOOGL)'s stock. This time, he discussed the firm's businesses and shared that the stock should be higher after the earnings: [GOOGL]'[On earnings report] Yeah, look cloud was important. I think the big focus is frankly, uh, that paid clicks picked up 4%. I mean I was thinking paid clips might be down, I was worried that I felt that this was the beginning of the erosion and the cannibalization versus Gemini. That was completely wrong. YouTube up 200 million. Really, really fantastic. . . .Look the story here is this that the more chips that they get, better they're doing. They have so much demand I was quite surprised. 20 New Technology Trends for 2024 'This stock should be up much more than that. While we acknowledge the potential of GOOGL as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Tesla, Inc. (TSLA)'s 'A Cult Stock,' Says Jim Cramer
Tesla, Inc. (TSLA)'s 'A Cult Stock,' Says Jim Cramer

Yahoo

timean hour ago

  • Yahoo

Tesla, Inc. (TSLA)'s 'A Cult Stock,' Says Jim Cramer

We recently published . Tesla, Inc. (NASDAQ:TSLA) is one of the stocks Jim Cramer recently discussed. Tesla, Inc. (NASDAQ:TSLA) continues to face a horrible time on the stock market in 2025. The firm's shares have lost 16.7% year-to-date and fell by 8.2% after its latest earnings report, which missed analyst revenue and earnings estimates. The results were so bad that even Cramer, who believes that Tesla, Inc. (NASDAQ:TSLA)'s potential is in emerging technologies such as robotics, was forced to do somewhat of a turnaround: '[on revenue, vehicle sold, carbon credit all down] Okay, so you listen to the conference call, and they made it so that those don't matter. All that matters is self drive, autonomous. I'm not kidding. Robotaxi, uh, Austin, California. And then there's some lines, which says, where he's saying, and David you'll get a kick out of this I'm sure, he's talking about like in a few years like everyone's gonna be in this. The robotaxi's like going great. I mean, it's not doing anything. This was a call that was a fatuous call. David, I left out Turkey, number one. Netherlands and Austria. I knew that Austrian market, that was it. 'It's a cult stock. . . This was not the kind of conference call that I expected. I did not expect an immediate pivot to robots and the self driving and the robotaxi. While we acknowledge the potential of TSLA as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store